▶ 調査レポート

世界の心肺停止治療市場（2023～2030）：治療法別（医薬品、医療機器）、流通チャネル別（病院、独立薬局）
• 英文タイトル：Cardiac Arrest Treatment Market by Treatment (Drug, Medical Devices), Distribution Channel (Hospitals, Independent Pharmacies) - Global Forecast 2023-2030

360iResearchが調査・発行した産業分析レポートです。世界の心肺停止治療市場（2023～2030）：治療法別（医薬品、医療機器）、流通チャネル別（病院、独立薬局） / Cardiac Arrest Treatment Market by Treatment (Drug, Medical Devices), Distribution Channel (Hospitals, Independent Pharmacies) - Global Forecast 2023-2030 / MRC2311A0159資料のイメージです。• レポートコード：MRC2311A0159
• 出版社/出版日：360iResearch / 2023年10月25日
• レポート形態：英文、PDF、196ページ
• 納品方法：Eメール（受注後2-3日）
• 産業分類：医療
• 販売価格（消費税別）
  Single User（1名利用、印刷不可、1年間閲覧）￥592,350 (USD3,949)▷ お問い合わせ
  Site License（同一拠点内共有可、印刷可）￥1,042,350 (USD6,949)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
心肺停止治療市場規模は、2022年の199.8億米ドルから2030年には400.3億米ドルに達すると予測、予測期間中の年平均成長率は9.06%です。
市場細分化とカバー範囲：
この調査レポートは、心肺停止治療市場の包括的な見通しを提供するために、様々なサブ市場を分析し、収益を予測し、各カテゴリの新たな動向を調査しています。
● 治療法に基づき、市場は医薬品と医療機器にわたって調査されます。薬剤はさらに、抗不整脈薬、抗コリン薬、ベータ遮断薬、副腎皮質ステロイド薬、線溶薬、血管圧迫薬にわたって調査します。医療機器は、心臓再同期療法と除細動器についてさらに詳しく調査しています。医療機器市場は予測期間中に大きな市場シェアを獲得すると予測されます。
● 流通チャネル別では、病院と個人薬局について調査しています。病院は予測期間中に大きな市場シェアを獲得すると予測されます。
● 地域別では、南北アメリカ、アジア太平洋、ヨーロッパ、中東、アフリカで調査を行いました。詳しい内訳は、南北アメリカはアルゼンチン、ブラジル、カナダ、メキシコ、アメリカを対象に、アメリカはさらにカリフォルニア、フロリダ、イリノイ、ニューヨーク、オハイオ、ペンシルバニア、テキサスを対象に調査を行いました。アジア太平洋地域は、オーストラリア、中国、インド、インドネシア、日本、マレーシア、フィリピン、シンガポール、韓国、台湾、タイ、ベトナムでした。ヨーロッパ・中東・アフリカは、デンマーク、エジプト、フィンランド、フランス、ドイツ、イスラエル、イタリア、オランダ、ナイジェリア、ノルウェー、ポーランド、カタール、ロシア、サウジアラビア、南アフリカ、スペイン、スウェーデン、スイス、トルコ、アラブ首長国連邦、イギリスを対象としています。2022年の市場シェアは南北アメリカが38.75%で最大、次いでヨーロッパ、中東・アフリカでした。

市場統計：
本レポートでは、主要7通貨（米ドル、ユーロ、日本円、英ポンド、豪ドル、カナダドル、スイスフラン）の市場規模と予測を提供しています。本レポートでは、2018年から2021年を過去年、2022年を基準年、2023年を推定年、2024年から2030年を予測期間としています。

FPNVポジショニングマトリックス：
FPNVポジショニングマトリックスは、心肺停止治療市場を評価するための不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります： フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析：
市場シェア分析では、心肺停止治療市場のベンダーランドスケープに関する貴重な洞察を提供します。全体的な収益、顧客基盤、その他の主要指標に対する影響を評価することで、各社の業績と直面している競争環境について包括的な理解を提供します。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競争レベルも明らかにします。

主要企業のプロフィール：
本レポートでは、心肺停止治療市場における最近の重要な動向を掘り下げ、主要ベンダーとその革新的なプロフィールを紹介しています。これには、Abbott Laboratories, Amgen Inc., Bayer AG, BIOTRONIK SE & CO., KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Fukuda Denshi Co., Ltd, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, Nihon Kohden Corporation, Novartis International AG, Pfizer Inc., Stryker Corporation, and ZOLL Medical Corporationなどが含まれます。

本レポートでは、以下の点について貴重な洞察を提供しています：
1. 市場浸透： 主要企業の市場ダイナミクスと製品に関する包括的な情報を提供します。
2. 市場開拓： 新興市場と成熟市場セグメントへの浸透を詳細に分析し、有利な機会を強調します。
3. 市場の多様化： 新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報を記載しています。
4. 競合他社の評価とインテリジェンス： 主要企業の市場シェア、戦略、製品、認証、規制当局の承認、特許状況、製造能力を網羅的に評価しています。
5. 製品開発とイノベーション： 将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を行いました。

本レポートは、以下のような主要な質問に対応しています：
1. 心肺停止治療市場の市場規模および予測はどのようになっていますか？
2. 心肺停止治療市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野はどこですか？
3. 心肺停止治療市場の機会を特定するための競争戦略窓口はどのようになっていますか？
4. 心肺停止治療市場における最新の技術動向と規制の枠組みはどのようになっていますか？
5. 心肺停止治療市場における主要ベンダーの市場シェアはどのようになっていますか？
6. 心肺停止治療市場への参入に適したモードと戦略的動きはどのようになっていますか？

1. 序論
2. 調査方法
3. エグゼクティブサマリー
4. 市場概要
5. 市場インサイト
6. 心肺停止治療の市場分析：治療法別
7. 心肺停止治療の市場分析：流通チャネル別
8. 南北アメリカの心肺停止治療市場
9. アジア太平洋の心肺停止治療市場
10. ヨーロッパ・中東・アフリカの心肺停止治療市場
11. 競争状況
12. 競争ポートフォリオ
13. 付録

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cardiac Arrest Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cardiac disorders worldwide
5.1.1.2. Government initiatives for cardiovascular health and wellness
5.1.1.3. Awareness related to advancements in medical devices for the treatment of cardiac arrest
5.1.2. Restraints
5.1.2.1. Expensive treatments associated with cardiac arrest
5.1.3. Opportunities
5.1.3.1. Emergence of minimally invasive procedures
5.1.3.2. Advancements in cardiac arrest treatments and procedures
5.1.4. Challenges
5.1.4.1. Lack of advanced healthcare infrastructure and skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Cardiac Arrest Treatment Market, by Treatment
6.1. Introduction
6.2. Drug
6.3.1. Anti-Arrhythmic Drugs
6.3.2. Anticholinergic Drugs
6.3.3. Beta Blockers
6.3.4. Corticosteroids
6.3.5. Fibrinolytic Drugs
6.3.6. Vasopressors
6.3. Medical Devices
6.4.1. Cardiac Resynchronization Therapy
6.4.2. Defibrillators
7. Cardiac Arrest Treatment Market, by Distribution Channel
7.1. Introduction
7.2. Hospitals
7.3. Independent Pharmacies
8. Americas Cardiac Arrest Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Cardiac Arrest Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Cardiac Arrest Treatment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Amgen Inc.
12.1.3. Bayer AG
12.1.4. BIOTRONIK SE & CO., KG
12.1.5. Boston Scientific Corporation
12.1.6. Bristol-Myers Squibb Company
12.1.7. Fukuda Denshi Co., Ltd
12.1.8. Johnson & Johnson Services, Inc.
12.1.9. Koninklijke Philips N.V.
12.1.10. LivaNova PLC
12.1.11. Medtronic PLC
12.1.12. Nihon Kohden Corporation
12.1.13. Novartis International AG
12.1.14. Pfizer Inc.
12.1.15. Stryker Corporation
12.1.16. ZOLL Medical Corporation
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

TABLE 1. CARDIAC ARREST TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. CARDIAC ARREST TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIAC ARREST TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 6. CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 8. CARDIAC ARREST TREATMENT MARKET SIZE, BY ANTI-ARRHYTHMIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CARDIAC ARREST TREATMENT MARKET SIZE, BY ANTICHOLINERGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CARDIAC ARREST TREATMENT MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CARDIAC ARREST TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CARDIAC ARREST TREATMENT MARKET SIZE, BY FIBRINOLYTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CARDIAC ARREST TREATMENT MARKET SIZE, BY VASOPRESSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 16. CARDIAC ARREST TREATMENT MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CARDIAC ARREST TREATMENT MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 19. CARDIAC ARREST TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CARDIAC ARREST TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 36. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 37. CANADA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 40. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 41. MEXICO CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CARDIAC ARREST TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 57. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 58. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 59. CHINA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 62. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 63. INDIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 70. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 71. JAPAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. THAILAND CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. THAILAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 94. THAILAND CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 95. THAILAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 107. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 108. DENMARK CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 111. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 112. EGYPT CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 114. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 115. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 116. FINLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 120. FRANCE CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 131. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 132. ITALY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. NORWAY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. NORWAY CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 143. NORWAY CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 144. NORWAY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. POLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. POLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 147. POLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 148. POLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 151. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 152. QATAR CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 167. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 168. SPAIN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 179. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 180. TURKEY CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM CARDIAC ARREST TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. CARDIAC ARREST TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 190. CARDIAC ARREST TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 191. CARDIAC ARREST TREATMENT MARKET LICENSE & PRICING

以下、関連資料のご紹介